Eticovo

Indicated For

rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, juvenile idiopathic arthritis

About This Medication

# Samsung Bioepis Patient Assistance Program: How to Get Eticovo at Low or No Cost ## About This Guide This guide explains how to access **Eticovo (etanercept-ykro)**, a prescription medication manufactured by Samsung Bioepis Co., Ltd., through patient assistance programs that may help reduce or eliminate your out-of-pocket costs. ## What is Eticovo? Eticovo is a **TNF blocker biosimilar** approved by the FDA to treat several autoimmune conditions. It is biosimilar to Enbrel (etanercept), meaning it works the same way in your body but is typically more affordable.[3][5] Eticovo is indicated for treating: - **Rheumatoid arthritis (RA)** in adults - **Polyarticular juvenile idiopathic arthritis (JIA)** in patients aged 2 years and older - **Psoriatic arthritis (PsA)** - **Ankylosing spondylitis (AS)** - **Plaque psoriasis (PsO)** in patients 4 years and older[4][5] In clinical trials, Eticovo demonstrated comparable safety and efficacy to the reference product, with an ACR20 response rate of 80.8% in rheumatoid arthritis patients.[5] ## Who Qualifies for Assistance? Patient assistance programs typically help individuals and families who: - Have limited income - Are uninsured or underinsured - Cannot afford their medications even with insurance - Meet specific income thresholds set by the manufacturer **Note:** Specific income eligibility limits for Samsung Bioepis's Eticovo assistance program are not publicly detailed in available resources. Contact Samsung Bioepis directly at **1-877-888-4231** to learn your program's exact income thresholds and eligibility requirements. ## Income Eligibility Most manufacturer assistance programs use federal poverty level (FPL) guidelines to determine eligibility. While Samsung Bioepis's specific thresholds for Eticovo are not publicly available, typical programs cover individuals and families earning up to 200-400% of the federal poverty level. **To determine your eligibility:** 1. Call Samsung Bioepis at 1-877-888-4231 2. Have your household income information ready 3. Ask about current income thresholds for your family size 4. Inquire about any special programs for uninsured or underinsured patients ## Insurance Requirements Assistance programs typically serve patients who are: - **Uninsured** (no health insurance coverage) - **Underinsured** (have insurance but face high copays, coinsurance, or deductibles) - **Medicare or Medicaid beneficiaries** with coverage gaps If you have insurance, the program may help cover your copay or coinsurance rather than providing the medication free. Contact Samsung Bioepis to discuss your specific insurance situation. ## How to Apply While specific application methods for Samsung Bioepis's Eticovo program are not detailed in public resources, most manufacturer programs follow these general steps: 1. **Call Samsung Bioepis** at 1-877-888-4231 to request an application or enrollment information 2. **Gather required documents**, which typically include: - Proof of income (recent tax return, pay stubs, or benefit statements) - Proof of citizenship or residency - Insurance information (if applicable) - A valid prescription from your healthcare provider 3. **Complete the application** (by phone, mail, or online) 4. **Submit documentation** as instructed by the program 5. **Await approval** and further instructions ## Timeline and Delivery The specific processing timeline for Samsung Bioepis's Eticovo assistance program is not publicly available. However, most manufacturer programs: - Process applications within **2-4 weeks** of receiving complete documentation - May provide expedited processing for urgent medical needs - Typically deliver medication via mail or arrange pickup at a pharmacy **Contact Samsung Bioepis at 1-877-888-4231** to ask about: - Expected processing time for your application - How medication will be delivered to you - Whether expedited processing is available ## What If Your Application Is Denied? If you are denied assistance, you have several options: 1. **Ask why you were denied** and whether you can reapply with additional information 2. **Explore alternative biosimilars** like Enbrel (etanercept), which may have its own assistance program 3. **Contact your healthcare provider** to discuss: - Whether a different medication might be more affordable - Whether your insurance can be appealed for coverage 4. **Seek help from patient advocacy organizations** that may offer additional resources or grants 5. **Ask your pharmacy** about generic alternatives or discount programs ## Reauthorization Assistance programs typically require periodic reauthorization to confirm continued eligibility. While specific reauthorization requirements for Samsung Bioepis's program are not publicly detailed, you should: - Expect to reauthorize **annually or as requested** by the program - Keep Samsung Bioepis informed of any changes in income or insurance status - Contact the program proactively if your circumstances change ## Important Safety Information Before starting Eticovo, inform your healthcare provider if you: - Have tuberculosis or have been exposed to tuberculosis - Have hepatitis B - Have a serious infection or sepsis - Are pregnant or planning to become pregnant - Are breastfeeding Eticovo carries a **boxed warning** for increased risk of serious infections and malignancies, including tuberculosis, bacterial sepsis, invasive fungal infections, and opportunistic infections.[3][4] ## Contact Information **Samsung Bioepis Co., Ltd.** - **Phone:** 1-877-888-4231 - **Website:** samsungbioepis.com - **To report adverse reactions:** 1-877-888-4231 or FDA at 1-800-FDA-1088 ## Disclaimer This guide provides general information about patient assistance programs and is not a substitute for professional medical or financial advice. Program details, eligibility requirements, and benefits may change. Always verify current program information directly with Samsung Bioepis Co., Ltd. before applying. Consult your healthcare provider about whether Eticovo is appropriate for your medical condition and to discuss any questions about your treatment plan.

Program information last verified: March 30, 2026